South Dakota 2022 Regular Session

South Dakota House Bill HB1054

Introduced
1/11/22  

Caption

Prohibit the isomerization and acetylation of cannabinoids and the sale and possession of products created by the isomerization and acetylation of cannabinoids and to provide a penalty therefor.

Impact

Should HB1054 be enacted, it would amend chapter 34-20B of South Dakota law, introducing stricter penalties for those involved in the sale or possession of chemically altered cannabinoid products. The bill enforces a Class 4 felony charge for engaging in isomerization or acetylation, while possession of such products is classified as a Class 5 felony. This creates a clear legal framework that directly targets the production and distribution of altered cannabis products, which proponents argue is necessary for public safety and health.

Summary

House Bill 1054 is a legislative proposal aimed at prohibiting the isomerization and acetylation processes of cannabinoids, which involve chemical alterations of cannabis compounds. The bill seeks to address the growing concerns regarding the production and sale of cannabinoid products that may be altered to enhance or change their effects. Specifically, it prohibits individuals from engaging in, selling, or possessing any materials created through these chemical processes. Violation of these provisions will lead to significant legal consequences, categorized as felonies under South Dakota law.

Contention

Debate surrounding HB1054 reflects broader concerns about regulation and control over cannabis-related substances. Proponents of the bill, likely concerned about consumer safety and drug potency, argue that it is crucial for regulating emerging cannabis products that may pose health risks. Conversely, opponents may view the restrictions as overly punitive, potentially stifling research and development within the cannabis industry. The bill's imposition of felony charges could also lead to issues of criminalization for those involved in the lawful use of cannabis products, raising concerns over equitable legal treatment.

Companion Bills

No companion bills found.

Previously Filed As

SD HB1056

Prohibit the preparation, sale, and distribution of certain kratom products and to provide a penalty therefor.

SD HB1125

Prohibit the chemical modification or conversion of industrial hemp and the sale or distribution of chemically modified or converted industrial hemp and to provide a penalty therefor.

SD SB00970

An Act Concerning Cannabinoids, Hemp And Hemp Products.

SD SB182

Psychoactive cannabinoids; prohibit sale of beverages containing psychoactive cannabinoids; criminal penalties provided

SD HB346

Hemp Products & Synthetic Cannabinoids

SD SB292

Prohibiting the transfer of hemp-derived cannabinoid products to any person under the age of 21, establishing packaging and labeling requirements for such products and amending the definition of industrial hemp and hemp products.

SD S1699

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

SD A1890

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

SD A5198

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

SD S3470

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

Similar Bills

MN SF781

Cannabis regulation authorization and appropriation

MN HF773

Regulation of concentration and conversion of cannabinoids derived from hemp provided, regulation of cannabinoid transportation and testing provided, licensing of manufacturers and distributors provided, cannabis product regulations provided, enforcement of regulations provided, licensing guidelines established, gross receipts tax established, criminal penalties established, exclusive liquor stores authorized to sell products, and money appropriated.

AZ SB1453

Hemp-derived impairing cannabinoids; regulation

UT HB0227

Hemp Amendments

SC S0137

Hemp-Derived Cannabinoids

UT HB0054

Cannabinoid Amendments

SC H3601

Hemp Derived Canabis

OR HB3295

Relating to cannabis; prescribing an effective date.